<DOC>
	<DOCNO>NCT00213798</DOCNO>
	<brief_summary>The majority lung cancer patient tumor-derived genetic alteration circulate plasma DNA could exploit diagnostic tool . The aim study evaluate plasma DNA use valuable non invasive test monitor disease progression without assess tumor .</brief_summary>
	<brief_title>Detection Plasma DNA Non Small Cell Small Cell Lung Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Presence lung tumor use fiberoscopy surgical intervention diagnosis . No lung instability . Individuals give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Lung cancer</keyword>
	<keyword>plasma DNA</keyword>
	<keyword>allelotyping</keyword>
	<keyword>follow-up</keyword>
	<keyword>Prospective Study</keyword>
	<keyword>Non-Small Cell Lung Cancer</keyword>
	<keyword>Small Cell Lung Cancer</keyword>
</DOC>